News

Discover the challenges surrounding AMED's merger with UnitedHealth, including regulatory concerns, imbalance in terms, and ...
Stifel downgraded Baxter International to ‘Hold’ from ‘Buy’ and slashed the price target to $25 from $36. The analysts ...